HealthQuiet 40d · day 40
GLP-1 drugs show promise against PCOS, hormonal disorder causing weight gain and facial hair
Glucagon-like peptide-1 medications are emerging as a treatment option for polycystic ovary syndrome, a condition that forces women to manage unwanted weight gain and facial hair.
What to know
- GLP-1 drugs, known for weight loss and diabetes treatment, show clinical promise against polycystic ovary syndrome (PCOS).
- PCOS is a hormonal disorder that causes persistent weight gain and excessive facial hair in women, significantly affecting quality of life.
- This finding may expand the therapeutic applications of GLP-1 medications beyond their current primary indications.
Laura Ungar Reporter, The Associated Press
The record 1 articles and posts · last 30 days